Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bodewell is a line of topical skincare products developed by **Procter & Gamble (P&G)** specifically for the management of chronic inflammatory skin conditions, including **atopic dermatitis (eczema)** and **psoriasis**. The products are formulated with a proprietary botanical blend known as **BW24**, which features *Rheum palmatum* (Chinese rhubarb) root extract, intended to provide anti-inflammatory benefits. The eczema-specific formulations typically include **colloidal oatmeal** as an FDA-recognized skin protectant to relieve minor skin irritation and itching, while the psoriasis products may contain **salicylic acid**. The brand was incubated within P&G Ventures to offer over-the-counter (OTC) solutions that support the skin barrier and reduce redness and irritation associated with sensitive skin conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bodewell.